Recent

% | $
Quotes you view appear here for quick access.

OCATA THERAPEUTICS, INC. Message Board

  • blidskar blidskar Jan 27, 2014 2:30 PM Flag

    Reason Buy and Hold

    The current trials are implanting only a fraction of the number of cells that the eye actually uses. Once the safety and tolerability is established with the FDA, they will have the green light increase the number greatly, which may prove to be even more therapeutic. Accumulate now, before the news.

    ClinicalTrials.gov Identifiers:
    NCT01345006 Estimated Study Completion Date: January 2014
    NCT01469832 Estimated Primary Completion Date: January 2014 (Final data collection date for primary outcome measure)

    Sentiment: Buy

 
OCAT
6.32-0.04(-0.63%)2:24 PMEDT